Clive Raymond Evjen Bramham is a Professor in the Department of Biomedicine at the University of Bergen. His research focuses on molecular mechanisms underlying synaptic plasticity and neurocognitive aging, with particular attention to Arc protein dynamics and translational regulation. He leads projects on traumatic brain injury amnesia and noncoding RNA roles in synaptic diseases. Education: Not explicitly stated in text. Research interests include synaptic plasticity, protein oligomerization, and gene expression in neurons. His work combines molecular biology, structural biology, and in-vivo neurobiology techniques. Recent studies investigate sex/gender impacts on neurocognitive aging and behavioral outcomes. Publications emphasize structural characterization of synaptic proteins and development of molecular tools for studying hippocampal neurons. No scientific awards explicitly listed. Advising: Supervised at least one Master's thesis (Anna Karisdotter Einarsen). Grants/Projects: Active in 'Amnesia after traumatic brain injury' and completed 'Noncoding RNA in synaptic plasticity and disease' projects. Labs/Teams: Collaborates in multi-institutional teams (NTNU, Oulu University, etc.) for hippocampal gene expression studies and neurobiological assays.
Martin Crespi is a CNRS Researcher at the Institute of Plant Sciences Paris-Saclay (IPS2) since 2018 and has led the "Regulatory RNAs in root plasticity" team since 2003. He served as Director of IPS2 (2015-2024), Director of the Plant Genomics Unit (2014-2015), and held leadership roles at CNRS institutions since 1994. Current Position: Researcher, CNRS, IPS2 Leadership: 14-member team (7 permanent) His research focuses on non-coding RNAs, epigenetics, and root development, exploring how riboregulators interact with splicing/chromatin factors to modulate root adaptability. His work bridges plant molecular biology, symbiosis, and environmental stress responses. Recent publications highlight his contributions to understanding RNA-mediated regulation in Arabidopsis and Medicago truncatula, covering topics like alternative splicing, chromatin looping, and miRNAome plasticity. These studies integrate genomics and molecular biology to decode root-soil interactions. Scientific Awards: Prix Dr. Pedro Berdoy (Argentina), National Society of Experimental Biology Award (Argentina) He has supervised 18 PhD students, 43 postdocs, and 14 Masters while leading 61 projects (including 9 EU grants and 7 Marie Curie grants) and participating in over 30 international scientific committees or review panels.
Dr. Ruth Mackenzie is a Research Associate at University of Glasgow specializing in cardiovascular health and weight management. Her work spans endothelial biology, bariatric surgery outcomes, and behavioral interventions for obesity. Key contributions: SCOTS cohort study on bariatric surgery outcomes Development of core outcome sets for weight management programs Endothelial dysfunction mechanisms in cardiovascular disease Standardization protocols for obesity intervention reporting
Eliane Sibler is a Researcher in the Department of Pharmacogenomics at ETH Zurich. She is affiliated with the Institute of Pharmaceutical Sciences (IPW) and part of the Professorship for Pharmacogenomics under Prof. M. Detmar. Her research focuses on blood and lymphatic vessels in inflammation and gene expression in vascular endothelial cells. Education: Ph.D. (2019–present) in Pharmacogenomics at ETH Zurich, Master of Pharmaceutical Sciences (2016–2018) with a thesis on long noncoding RNAs in lymphatic endothelial cells, and Bachelor of Pharmaceutical Sciences (2012–2016) from ETH Zurich. She has been a research assistant in Prof. Detmar’s lab since 2016 and is a member of the LSZGS Molecular Life Science Program. Her recent publications (2021) explore antisense oligonucleotide controls, single-cell analysis of lymphatic endothelial cells, and the role of lncRNAs in vascular biology. These studies highlight her expertise in molecular mechanisms governing vascular function and inflammation. No scientific awards are explicitly listed. Her work contributes to interdisciplinary research within the Institute, focusing on translational pharmacogenomics and vascular biology.
Albert Tai is a Research Assistant Professor in the Department of Immunology at Tufts University School of Medicine. He leads genomics and flow cytometry efforts within the department and the broader School of Medicine. His research focuses on immunological mechanisms, aging-related inflammation, and cellular signaling pathways, with significant contributions to understanding STING-dependent pathways and tissue homeostasis. Tai has held positions including Genomics Core Manager and Scientific Consultant, reflecting his expertise in translational and technical research. His educational background includes a PhD from Tufts University (2006) and a BS from Hong Kong Polytechnic University (1996). His teaching spans courses like Graduate Biochemistry and System Approaches to Immunology. Notable grants include NIH-funded projects on innate immune memory, nucleic acid sensing in aging, and T cell activation in heart failure. Awards include the 2014 Tufts Extra Mile Award for exceptional service. Tai’s work integrates interdisciplinary approaches, addressing critical questions in immunology, cardiology, and infectious diseases through collaborative research and advanced genomic techniques.
Jessica Bryant is a Research Fellow in the Biology of Host-Parasite Interactions Unit within the Department of Parasites and Insect Vectors at the Institut Pasteur, Paris. She conducts cutting-edge research on epigenetic and transcriptional regulation in Plasmodium falciparum , the deadliest malaria parasite, focusing on the var multigene family and antigenic variation. Ph.D. in Cell and Molecular Biology, University of Pennsylvania (2008–2014) B.S. in Cellular Biology, University of Georgia (2004–2008) Her research expertise lies in chromatin biology, gene regulation, and CRISPR-based technologies in parasitology. She investigates how epigenetic mechanisms control virulence gene expression and immune evasion in malaria parasites. Her work integrates molecular biology, genomics, and functional assays to dissect transcriptional networks in Plasmodium . The recent publications highlight a strong focus on CRISPR applications, m6A mRNA methylation, noncoding RNA regulation, and chromatin remodeling in Plasmodium . These studies reveal complex regulatory layers controlling antigenic variation and stage-specific gene expression, with implications for malaria pathogenesis and therapeutic development. Scientific Awards and Fellowships: EMBO Long-term Postdoctoral Fellowship (2015–2017) Institut Pasteur Roux-Cantarini Postdoctoral Fellowship (2015–2016) Goldwater Scholar (2008) Biomedical Graduate Studies Travel Grant (2012, 2013) University of Pennsylvania Genetics T32 Training Grant (2010–2012) Jessica Bryant has contributed significantly to mentoring and scientific community building, having served as Departmental Postdoc Representative at the Institut Pasteur. She has taught epigenetics and next-generation sequencing courses at Sorbonne University and the University of Bern. She co-organized the international CRISPR in Parasitology Symposium, fostering collaboration across the field. Her research is supported by prestigious grants and conducted within a leading parasitology research unit, with no indication of retirement or former status.
Valérie Hilgers is a Group Leader at the Max Planck Institute of Immunobiology & Epigenetics, leading the Laboratory for RNA Processing in the Nervous System. Her research focuses on the molecular mechanisms underlying neuron-specific RNA signatures and their role in neural development and function. She employs Drosophila melanogaster as a model system, leveraging techniques such as functional genetics, imaging, and advanced transcriptomics (iCLIP, RNA-seq, ultra-long-read sequencing). Her work bridges transcriptional and post-transcriptional RNA regulation, investigating how these processes shape neuronal function in health and disease. Key projects include understanding mRNA isoform selection, non-coding RNA roles in neuronal granules, and the regulatory functions of ELAV/Hu proteins. Recent studies highlight ELAV's role in circular RNA biogenesis and Pumilio's control of synaptic protein localization. Publications span high-impact journals like Cell and Science Advances, with a focus on RNA diversity and its implications for neurological disorders. Collaborations include work with the Lagha lab on live imaging and participation in conferences like EMBL's 'Gene Regulation: One Molecule at a Time.'
Kannanganattu V. Prasanth is a Professor of Cell & Developmental Biology at the University of Illinois Urbana-Champaign’s School of Molecular & Cellular Biology. His research focuses on understanding the roles of long noncoding RNAs (lncRNAs) in nuclear domains, cancer progression, and cell cycle regulation. He holds a Ph.D. in Cytogenetics from Banaras Hindu University and completed postdoctoral training at Cold Spring Harbor Laboratory. Research Interests: Regulation of gene expression via lncRNAs in nuclear domains like speckles and nucleoli Role of lncRNAs in cancer metastasis and tumor biology Cell cycle-regulated lncRNAs and their impact on proliferation Mechanisms of RNA phase separation and condensate formation Functional genomics of nucleolar organizer region-derived lncRNAs Recent Highlights: Discovered MALAT1’s role in splicing factor organization and cancer metastasis Identified SUNO1 lncRNA’s regulation of Hippo signaling in cell proliferation Characterized nucleolar territories formed by monoallelic lncRNAs Awards: EAGER NSF award American Cancer Society Research Scholar Cancer Center at Illinois seed grants Labs/Teams: Leads the Prasanth Lab, which integrates molecular, cellular, and genomic approaches to study lncRNA function in health and disease.
Kannanganattu V Prasanth is a Professor in the Department of Cell and Developmental Biology at the University of Illinois. His research focuses on long noncoding RNAs (lncRNAs) and their role in gene regulation, particularly during cancer progression. His primary research interests include: Regulation of Gene Expression RNA Biology Nuclear domain organization and structure Long noncoding RNA mechanisms in cancer Prasanth's laboratory investigates how nuclear domain-enriched lncRNAs control gene expression through modulation of nuclear domains and associated chromatin structure. His work demonstrates that lncRNAs like MALAT1 regulate vital cellular processes by functioning as 'scaffolds' or 'guides' to modulate protein interactions. He has established connections between nuclear speckle-localized RNAs and cancer progression, showing how MALAT1 depletion reduces tumorigenic properties while its overexpression enhances tumor metastasis. His recent publications reveal significant findings in lncRNA biology, including characterization of cell cycle-regulated lncRNAs and their role in breast cancer progression, particularly in triple-negative breast cancer. His work on MANCR lncRNA and MALAT1 has provided important insights into RNA-mediated gene regulatory mechanisms. Prasanth has received several honors including an EAGER NSF award, Research Scholar from the American Cancer Society, and Cancer Center at Illinois seed grants. His laboratory employs cellular and molecular biological approaches to unravel lncRNA functions in mammalian cells, with particular focus on nuclear speckles, paraspeckles, and nucleolar domains. Current research directions include investigating phase separation mechanisms within nuclear speckles and CRISPR-based approaches to characterize lncRNA functions in cancer cells.
Lisa L Hall-Anderson is an Associate Professor at UMass Chan Medical School, holding positions in the Department of Neurology at the T.H. Chan School of Medicine, the NeuroNexus Institute, and the Neuroscience Department at the Morningside Graduate School of Biomedical Sciences. She has been collaborating with Dr. Jeanne Lawrence in the Department of Neurology since 1999, focusing on fundamental questions about genome regulation and their clinical implications in epigenetics. Her educational background includes: BA in Biology from Colorado College, Colorado Springs, CO PhD in Genetics from University of California, Davis, CA Dr. Hall-Anderson's research centers on the functional organization of the nucleus and its role in gene expression during differentiation and disease. Her primary research interests include: How long non-coding RNAs interact with chromatin The functional importance of the repeat genome in gene regulation and nuclear structure Epigenetic mechanisms of X-chromosome inactivation Developing novel gene therapy approaches for Down syndrome by silencing the extra chromosome 21 Her publication record demonstrates a consistent focus on nuclear architecture, noncoding RNA biology, and epigenetic regulation. Recent work has particularly emphasized the role of repetitive DNA elements in chromosome organization and the therapeutic potential of XIST RNA for trisomy 21 correction. Her research bridges fundamental chromosome biology with translational applications, especially in the context of Down syndrome. As a key member of Dr. Jeanne Lawrence's laboratory, Dr. Hall-Anderson has contributed significantly to establishing XIST RNA as the first long non-coding RNA that "paints" the entire inactive X-chromosome. Her work has helped pioneer the understanding of how non-coding RNA can control whole-chromosome regulation, with implications for both basic science and clinical applications in chromosome disorders. Dr. Hall-Anderson's laboratory work involves molecular cytology approaches, transgenics, bioinformatics, and cytological epigenetics to study how XIST RNA interacts with chromosomes. Since 2007, she has been involved in an ambitious project translating chromosome biology discoveries into a novel approach for correcting trisomy 21 in Down syndrome, demonstrating that the XIST gene can be targeted into extra chromosome 21 in patient-derived cells to repress transcription.
Veronica Julia Peschansky is an Assistant Professor at UMass Chan Medical School's T.H. Chan School of Medicine in the Department of Neurology. Her research spans molecular neuroscience, epigenetic regulation, and neurocritical care. Biology BS from Brandeis University MD and PhD in Neuroscience from University of Miami School of Medicine Her work focuses on non-coding RNAs in neural precursor cells, glioblastoma pathogenesis, and neurological complications of viral infections. Recent studies examine long noncoding RNAs like FMR4 and HOTAIR in neurodegenerative disorders and RNA interference mechanisms. Publications show interdisciplinary engagement with molecular biology, cell biology, and nanotechnology applications in neurology. Key subtopics include epigenetic gene regulation, neurodevelopmental disorders, and magnetic field-guided therapies.
Dr. Viswanathan (Vishwa) Rajagopalan serves as an Associate Professor in the Department of Biomedical & Anatomical Sciences; Cardiovascular Medicine; Molecular and Translational Physiology at NYITCOM-Arkansas (New York Institute of Technology), hosted on the campus of Arkansas State University where he educates future physicians and researchers. His research program investigates the functional roles of long noncoding RNAs in cardiovascular and thyroid pathologies through advanced biomedical methodologies. This work targets the development of novel diagnostic platforms and therapeutic interventions to address unmet clinical needs in cardiovascular and integrative medicine, with emphasis on translational applications for patient care. Dr. Rajagopalan actively mentors medical students, undergraduate trainees, and research scholars, providing hands-on research experience that frequently results in co-authorship for mentees on peer-reviewed publications and conference presentations.
Dr. Vinicio de Jesus Perez is a Professor of Medicine in the Department of Pulmonary, Allergy & Critical Care Medicine at Stanford University School of Medicine, where he also serves as Associate Dean of MD Admissions. He holds multiple affiliations including membership in the Cardiovascular Institute, Bio-X, Maternal & Child Health Research Institute, and Wu Tsai Neurosciences Institute. Dr. Perez received his MD from the University of Puerto Rico Medical School, completed internal medicine residency at Massachusetts General Hospital, and pulmonary/critical care fellowship in Denver followed by postdoctoral research training at Stanford University. His educational background reflects excellence with Summa cum Laude distinctions in both Biology (1996) and Medicine (2000). His research focuses on the molecular mechanisms of pulmonary hypertension (PH) and idiopathic pulmonary fibrosis (IPF), with particular interest in genetic factors, vascular remodeling, and novel therapeutic targets. He leads a research program identifying new treatments for PH and IPF, with recent work examining pericyte biology, Wnt signaling pathways, and digital monitoring technologies. Dr. Perez has made significant contributions to understanding drug-induced pulmonary hypertension and health disparities in PH patients. His recent publications demonstrate a strong focus on translational research, with emphasis on cellular mechanisms of vascular remodeling, novel genetic variants associated with PH, and innovative approaches to disease monitoring. The work spans molecular biology, clinical trials, and implementation of digital health technologies for improved patient management. Beta Beta Beta Award, Beta Beta Beta (1996) Summa cum Laude distinctions in Biology and Medicine American Lung Association Career Development Award (2008) Distinguished Faculty Fellow, Stanford University (2013) Faculty of 1000 Faculty Member of the Year for Respiratory Disorders (2014) AHA Mid Career Award (2024) Dr. Perez actively mentors postdoctoral fellows and graduate students, including Eleana Guardado, Arpita Roy, and Sucheta Chopra. His research has been supported by numerous grants from the NIH, American Heart Association, American Lung Association, and private foundations. He leads the Stanford Adult PH Clinic and directs several collaborative research initiatives including the Stanford Translational Investigator Program (2016-2024). His laboratory investigates pulmonary vascular biology with emphasis on pericyte-endothelial interactions, genetic mechanisms of disease, and novel therapeutic targets. Dr. Perez maintains active collaborations with institutions worldwide including University of Puerto Rico, Lund University, Karolinska Institute, and University of Graz, focusing on international translation of research findings and education in pulmonary vascular medicine.
Pranabananda Dutta serves as an Assistant Professor in the College of Medicine at Charles R. Drew University of Medicine and Science, where his research centers on molecular oncology with emphasis on breast, lung, and prostate cancers. He investigates health disparities affecting African American and Hispanic populations through the lens of obesity, diabetes, hypertension, and genetic variations influencing cancer risk and progression. His research program spans epigenetic regulation , STAT signaling pathways , and inflammatory cytokine networks in tumor microenvironments. Key interests include DNA methylation profiles in obese patients, CCL2/PARP1-driven cancer invasiveness, PD-L1 biomarker validation, and heterochromatin-modulating drugs like methotrexate. His work consistently addresses health inequities by examining how social determinants intersect with molecular mechanisms to worsen cancer outcomes in underserved communities. Analysis of his 2019-2024 publications reveals three dominant trends: (1) Breast cancer mechanisms in minority populations, particularly triple-negative subtypes linked to obesity and inflammation; (2) Epigenetic drivers of tumor suppression involving STAT proteins and heterochromatin formation; (3) Translational exploration of drug repurposing (e.g., methotrexate) and novel targets like CARF in prostate cancer metastasis. His studies frequently employ genomic, transcriptomic, and epigenomic approaches to address health disparities. Scientific awards: No honors, fellowships, or medals are documented in the provided materials. While specific advising activities and grant details remain undisclosed in available sources, his publication record indicates active mentorship in cancer biology research. Multiple collaborative studies on breast cancer disparities and epigenetic mechanisms suggest involvement in team science, though formal grant listings are absent from the scraped content. Lab and team structures are not explicitly described, but his research on tumor microenvironments, cytokine networks, and health disparities implies participation in multidisciplinary oncology initiatives at Charles R. Drew University, likely involving clinical collaborators focused on underserved patient populations in South Los Angeles.
Dr. Girish Shukla is a Professor at Cleveland State University affiliated with the Center for Gene Regulation in Health and Disease (GRHD), focusing on molecular mechanisms of eukaryotic gene expression at the RNA level. His research spans RNA biology, cancer therapeutics, and gene regulation. His primary research interests include: Molecular mechanisms of eukaryotic gene expression at the RNA level Noncoding RNAs and their regulatory roles Nuclear pre-mRNA splicing and minor spliceosome dynamics RNA:RNA and RNA:Protein interactions Post-transcriptional control in prostate cancer miRNA-mediated androgen receptor regulation Steroid biosynthesis pathways as cancer therapeutic targets Analysis of Dr. Shukla's recent publications reveals a strong emphasis on microRNA regulation in prostate cancer progression, with significant work on androgen receptor control mechanisms. His research increasingly integrates computational biology with molecular approaches to identify cancer biomarkers and therapeutic targets, particularly in RNA metabolism and noncoding RNA functions. The publications demonstrate consistent contributions to understanding spliceosomal mechanisms and their dysregulation in hematological cancers. Dr. Shukla actively mentors graduate researchers, including PhD student Asmita Bhattarai, within the GRHD center's collaborative environment. His laboratory employs cutting-edge molecular, biochemical, and computational tools to investigate RNA-protein interactions and splicing mechanisms. The Center for Gene Regulation in Health and Disease provides infrastructure for interdisciplinary research through its CSU/Cleveland Clinic Joint Ph.D. Programs and shared instrumentation facilities.
